1Gutteridge, JM (1994) Biological origin of free radicals, and mechanisms of antioxidant protection. Chem Biol Interact 91, 133–140.
2Rock, CL, Jacob, RA & Bowen, PE (1996) Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J Am Diet Assoc 96, 693–702.
3World Health Organization (2003), Diet, Nutrition and the Prevention of Chronic Diseases, . Geneva: WHO.
4Bazzano, LA, He, J, Ogden, LG, Loria, CM, Vupputuri, S, Myers, L & Whelton, PK (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76, 93–99.
5Ford, ES & Mokdad, AH (2001) Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults. Prev Med 32, 33–39.
6Montonen, J, Jarvinen, R, Heliovaara, M, Reunanen, A, Aromaa, A & Knekt, P (2005) Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr 59, 441–448.
7Stanner, SA, Hughes, J, Kelly, CN & Buttriss, J (2004) A review of the epidemiological evidence for the ‘antioxidant hypothesis’. Public Health Nutr 7, 407–422.
8Comstock, GW, Bush, TL & Helzlsouer, K (1992) Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135, 115–121.
9Knekt, P, Ritz, J, Pereira, MA, et al. (2004) Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80, 1508–1520.
10Ford, ES, Will, JC, Bowman, BA & Narayan, KM (1999) Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149, 168–176.
11Törnwall, ME, Virtamo, J, Korhonen, PA, Virtanen, MJ, Taylor, PR, Albanes, D & Huttunen, JK (2004) Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur Heart J 25, 1171–1178.
12Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23–33.
13Rapola, JM, Virtamo, J, Ripatti, S, Huttunen, JK, Albanes, D, Taylor, PR & Heinonen, OP (1997) Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349, 1715–1720.
14Liu, S, Ajani, U, Chae, C, Hennekens, C, Buring, JE & Manson, JE (1999) Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 282, 1073–1075.
15El-Agamey, A, Lowe, GM, McGarvey, DJ, Mortensen, A, Phillip, DM, Truscott, TG & Young, AJ (2004) Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 430, 37–48.
16National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421.
17Grundy, SM (2005) Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 25, 2243–2244.
19Esmaillzadeh, A, Kimiagar, M, Mehrabi, Y, Azadbakht, L, Hu, FB & Willett, WC (2007) Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 85, 910–918.
20Yoo, S, Nicklas, T, Baranowski, T, Zakeri, IF, Yang, SJ, Srinivasan, SR & Berenson, GS (2004) Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr 80, 841–848.
21Sonnenberg, L, Pencina, M, Kimokoti, R, Quatromoni, P, Nam, BH, D'Agostino, R, Meigs, JB, Ordovas, J, Cobain, M & Millen, B (2005) Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res 13, 153–162.
22Kim, MH, Lee, HS, Park, HJ & Kim, WY (2007) Risk factors associated with metabolic syndrome in Korean elderly. Ann Nutr Metab 51, 533–540.
23Sentí, M, Tomás, M, Fitó, M, Weinbrenner, T, Covas, MI, Sala, J, Masiá, R & Marrugat, J (2003) Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 88, 5422–5426.
24Ford, ES, Mokdad, AH, Giles, WH & Brown, DW (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52, 2346–2352.
25Lee, KU (2001) Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 54, S29–S33.
26Hansel, B, Giral, P, Nobecourt, E, Chantepie, S, Bruckert, E, Chapman, MJ & Kontush, A (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89, 4963–4971.
27Jay, D, Hitomi, H & Griendling, KK (2006) Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40, 183–192.
28Griendling, KK & FitzGerald, GA (2003) Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108, 2034–2040.
29Oberly, LW (1988) Free radicals and diabetes. Free Radic Biol Med 5, 113–124.
30Dandona, P, Thusu, K, Cook, S, Snyder, B, Makowski, J, Armstrong, D & Nicotera, T (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347, 444–445.
31Reilly, M, Delanty, N, Lawson, JA & FitzGerald, GA (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 19–25.
32Pryor, WA & Stone, K (1993) Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686, 12–27.
33Morrow, JD, Frei, B, Longmire, AW, Gaziano, JM, Lynch, SM, Shyr, Y, Strauss, WE, Oates, JA & Roberts, LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332, 1198–1203.
34Facchini, FS, Hollenbeck, CB, Jeppesen, J, Chen, YD & Reaven, GM (1992) Insulin resistance and cigarette smoking. Lancet 339, 1128–1130.
35Attvall, S, Fowelin, J, Lager, I, Von Schenck, H & Smith, U (1993) Smoking induces insulin resistance – a potential link with the insulin resistance syndrome. J Intern Med 233, 327–332.
36Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
37Sugiura, M, Nakamura, M, Ikoma, Y, Yano, M, Ogawa, K, Matsumoto, H, Kato, M, Ohshima, M & Nagao, A (2005) High serum carotenoids are inversely associated with serum gamma-glutamyltransferase in alcohol drinkers within normal liver function. J Epidemiol 15, 180–186.
38Wakai, K, Egami, I, Kato, K, et al. (1999) A simple food frequency questionnaire for Japanese diet – Part I. Development of the questionnaire, and reproducibility and validity for food groups. J Epidemiol 9, 216–226.
39Egami, I, Wakai, K, Kato, K, et al. (1999) A simple food frequency questionnaire for Japanese diet – Part II. Reproducibility and validity for nutrient intakes. J Epidemiol 9, 227–234.
40Science and Technology Agency (1983) Standard Tables of Food Composition in Japan, 4th ed.Tokyo: Printing Bureau, Ministry of Finance .
41Committee to Evaluate Diagnostic Standards for Metabolic Syndrome (2005) Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 94, 794–809, .
42Matsuzawa, Y (2005) Metabolic syndrome – definition and diagnostic criteria in Japan. J Atheroscler Thromb 12, 301.
43Matsuzawa, Y, Inoue, S, Ikeda, Y, et al. (2000) New definition of obesity and diagnostic criteria for high-risk obesity. Himan Kenkyu 6, 12–28.
44Hak, AE, Stampfer, MJ, Campos, H, Sesso, HD, Gaziano, JM, Willett, W & Ma, J (2003) Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 108, 802–807.
45Liu, S, Lee, IM, Ajani, U, Cole, SR, Buring, JE & Manson, JE (2001) Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: the Physicians' Health Study. Int J Epidemiol 30, 130–135.
46Hozawa, A, Jacobs, DR Jr, Steffes, MW, Gross, MD, Steffen, LM & Lee, DH (2006) Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163, 929–937.
47Kannel, WB & Higgins, M (1990) Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens 8, S3–S8.
48Peng, YM, Peng, YS, Lin, Y, Moon, T, Roe, DJ & Ritenbaugh, C (1995) Concentrations and plasma–tissue–diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 23, 233–246.
49Dietrich, M, Block, G, Norkus, EP, Hudes, M, Traber, MG, Cross, CE & Packer, L (2003) Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 77, 160–166.
50Nakanishi, N, Takatorige, T & Suzuki, K (2005) Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health 43, 295–301.
51Wada, T, Urashima, M & Fukumoto, T (2007) Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med 46, 1079–1082.
52Ishizaka, N, Ishizaka, Y, Toda, E, Nagai, R & Yamakado, M (2007) Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med 46, 1167–1170.
53Pouliot, MC, Despres, JP, Lemieux, S, Moorjani, S, Bouchard, C, Tremblay, A, Nadeau, A & Lupien, PJ (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumula-tion and related cardiovascular risk in men and women. Am J Cardiol 73, 460–468.
54Wei, M, Gaskill, SP, Haffner, SM & Stern, MP (1997) Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans – a 7-year prospective study. Obes Res 5, 16–23.
55Sattar, N, Tan, CE, Han, TS, Forster, L, Lean, ME, Shepherd, J & Packard, CJ (1998) Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 22, 432–439.
56Stevens, J, Couper, D, Pankow, J, Folsom, AR, Duncan, BB, Nieto, FJ, Jones, D & Tyroler, HA (2001) Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9, 696–705.
57Dalton, M, Cameron, AJ, Zimmet, PZ, Shaw, JE, Jolley, D, Dunstan, DW, Welborn, TA & AusDiab Steering Committee (2003) Waist circumference, waist–hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254, 555–563.
58Vazquez, G, Duval, S, Jacobs, DR Jr & Silventoinen, K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29, 115–128.